MYLAN-AZELASTINE/FLUTICASONE
MYLAN-AZELASTINE/FLUTICASONE
Approved
DIN Number
02530341
Drug Class
Human
Market Date
Aug 16, 2023
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02530341
AIG Number0256150002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD58 FLUTICASONE, COMBINATIONS
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification04:08.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
AZELASTINE HYDROCHLORIDEActive
Strength: 137 MCG / ACT
Monograph: AZELASTINE HYDROCHLORIDE
FLUTICASONE PROPIONATEActive
Strength: 50 MCG / ACT
Monograph: FLUTICASONE PROPIONATE